8-K
filed September 1, 2026, 6:09 PM ET
ticker BRTX
CIK 0001505497
leadership
confidence high
sentiment negative
materiality 0.75
BioRestorative appoints Mika Grasso interim CEO, Anna Skowron CFO; dismisses auditor CBIZ
BioRestorative Therapies, Inc.
- Katharyn Field steps down as interim CEO/CFO, resigns from board; consulting deal with EEAK at $10k/month.
- Mika Grasso appointed interim CEO effective Aug 26, 2026; consulting deal with Currensea Capital at $10k/month.
- Anna Skowron appointed CFO effective Aug 27, 2026; consulting deal with BPC Consulting at $12k/month.
- Dismissed CBIZ as auditor, engaged Bush & Associates CPA; CBIZ report had going concern explanatory paragraph.
- No disagreements with CBIZ on accounting principles; audit committee changes: Steven Brown named chair.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Mika Grasso was appointed as Interim Chief Executive Officer at BioRestorative Therapies, Inc..
- Action
- appointed
- Role
- Interim Chief Executive Officer
Exact text from the filing
On August 26, 2026, the Board appointed Mika Grasso as the Company’s Interim Chief Executive Officer, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.8
Katharyn Field departed as Chief Financial Officer at BioRestorative Therapies, Inc..
- Action
- ceased to serve
- Role
- Chief Financial Officer
Exact text from the filing
Ms. Field also ceased to serve as the Company’s interim Chief Financial Officer and Treasurer effective August 27, 2026, upon the appointment of her successor as described below
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Katharyn Field departed as Interim Chief Executive Officer at BioRestorative Therapies, Inc..
- Action
- stepped aside
- Role
- Interim Chief Executive Officer
Exact text from the filing
On August 26, 2026, Katharyn Field advised the Board that she wished to step aside as the Company’s Interim Chief Executive Officer and Chief Financial Officer, and the Board accepted her request effective as of that date.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Steven Brown was appointed as Chairman of the Board at BioRestorative Therapies, Inc..
- Action
- appointed
- Role
- Chairman of the Board
Exact text from the filing
On September 1, 2026, the Board also appointed Mr. Brown as Chairman of the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.9
Katharyn Field resigned as Director at BioRestorative Therapies, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
and resigned as a member of the Board effective August 31, 2026.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.